Physician
Psychiatry
Dr. Neal R. Cutler, MD
|
|
Give Review
Neal Cutler practices Psychiatry. He attended Saint Louis University School of Medicine. Saint Louis University School of Medicine is ranked 67 in research and 57 in primary care medicine Neal R. Cutler is also published. He has 101 publications published. The lastest publication: "Efficacy of xanomeline in Alzheimer disease: cognitive improvement measured using the Computerized Neuropsychological Test Battery (CNTB).'
Publications
- Exploratory Biomarker Study of the Triple Reuptake Inhibitor SEP-432 Compared to the Dual Reuptake Inhibitor Duloxetine in Healthy Normal Subjects.
- The effect of naltrexone on sleep parameters in healthy male volunteers.
- Balancing risk and benefit in venous thromboembolism trials: concept for a bivariate endpoint trial design and analytic approach.
- The Impact of Gender on Antidepressants.
- A randomized evaluation of the effects of six antipsychotic agents on QTc, in the absence and presence of metabolic inhibition.
- The effect of antipsychotics on plasma lipids.
- Galantamine hydrobromide: an agent for Alzheimer's disease.
- Centrally acting antiemetics mitigate nausea and vomiting in patients with Alzheimer's disease who receive rivastigmine.
- Brasofensine treatment for Parkinson's disease in combination with levodopa/carbidopa.
- Rizatriptan (MAXALT) for the acute treatment of migraine and migraine recurrence. A placebo-controlled, outpatient study. Rizatriptan 022 Study Group.
- Pharmacotherapy in Alzheimer''s disease: basis and rationale.
- Clinical history, brain metabolism, and neuropsychological function in Alzheimer's disease.
- Relations between neuropsychological and cerebral metabolic asymmetries in early Alzheimer's disease.
- A dose-response trial of once-daily diltiazem.
- Low dose bromocriptine: a study of acute effects in chronic mediated schizophrenics.
- Sertraline in children and adolescents with obsessive-compulsive disorder: a multicenter randomized controlled trial.
- Cerebral metabolism as measured with positron emission tomography (PET) and [18F] 2-deoxy-D-glucose: healthy aging, Alzheimer''s disease and Down syndrome.
- Brain metabolism as measured with positron emission tomography: serial assessment in a patient with familial Alzheimer's disease.
- A placebo-controlled trial of L-365,260, a CCKB antagonist, in panic disorder.
- Oral sumatriptan in preventing headache recurrence after treatment of migraine attacks with subcutaneous sumatriptan.
- Implications of dosing tricyclic antidepressants and benzodiazepines in geriatrics.
- A treatment and withdrawal trial of besipirdine in Alzheimer disease.
- Oral sumatriptan for the long-term treatment of migraine: clinical findings.
- Combined enalapril and felodipine extended release (ER) for systemic hypertension. Enalapril-Felodipine ER Factorial Study Group.
- State-related cyclical dyskinesias in manic-depressive illness.
- Methodological concerns: evaluating central nervous system (CNS) active compounds in Alzheimer's disease (AD).
- Distinct mechanism for antidepressant activity by blockade of central substance P receptors.
- The status of ongoing trials for mild cognitive impairment.
- Investigator perspective on MTD: practical application of an MTD definition--has it accelerated development?
- Placebo-controlled evaluation of three doses of a controlled-onset, extended-release formulation of verapamil in the treatment of stable angina pectoris.
- Dose-ranging study of a new, once-daily diltiazem formulation for patients with stable angina.
- Tacrine in Alzheimer's disease.
- Poor tolerability of MK-458.
- Comparison of quantitative methodologies to define chronic pressure ulcer measurements.
- The use of placebo controls.
- Compliance in hypertension: daily v twice daily.
- Arrhythmia due to hypervagotonia in a fit pharmacology volunteer.
- Evaluation of zimeldine in Alzheimer's disease. Cognitive and biochemical measures.
- Placebo-controlled comparison of the clinical effects of rapid discontinuation of ipsapirone and lorazepam after 8 weeks of treatment for generalized anxiety disorder.
- Evaluation of an analogue of somatostatin (L363,586) in Alzheimer's disease.
- CSF and serum concentrations of albumin and IgG in Alzheimer's disease.
- Cognitive and brain imaging measures of Alzheimer's disease.
- Steady-state pharmacokinetics of tacrine in patients with Alzheimer's disease.
- Subjective neuroleptic response and treatment outcome under open and double-blind conditions--a preliminary report.
- The bridging concept: optimizing dose for phase II/III in Alzheimer''s disease.
- Oral sumatriptan for the acute treatment of migraine: evaluation of three dosage strengths.
- Prevalence of tardive dyskinesia among three ethnic groups of chronic psychiatric patients.
- Pharmacokinetic studies of antipsychotics in healthy volunteers versus patients.
- Cholinesterase inhibitors: a therapeutic strategy for Alzheimer disease.
- Fleroxacin treatment of stage IV pressure ulcers with associated osteomyelitis.
- Effect of the ACE inhibitor ceronapril on cerebral blood flow in hypertensive patients.
- Psychomotor and memory effects of two adinazolam formulations assessed by a computerized neuropsychological test battery.
- Idioventricular rhythm: hypervagotonia associated with placebo.
- Inhibition of acetyl- and butyryl-cholinesterase in the cerebrospinal fluid of patients with Alzheimer''s disease by rivastigmine: correlation with cognitive benefit.
- Review of the acetylcholinesterase inhibitor galanthamine.
- Assessing the neuropsychological profile of stable schizophrenic outpatients.
- Pharmacokinetics of co-administered didanosine and stavudine in HIV-seropositive male patients.
- Monitoring of acute migraine attacks: placebo response and safety data.
- A bridging study of fananserin in schizophrenic patients.
- Pharmacokinetics of rizatriptan tablets during and between migraine attacks.
- RBC cholinesterase inhibition: a useful surrogate marker for cholinesterase inhibitor activity in Alzheimer disease therapy?
- Women's health care during the perimenopause.
- Beta-amyloid therapies in Alzheimer''s disease.
- Guidelines for conducting bridging studies in Alzheimer disease.
- Penetration of trovafloxacin into cerebrospinal fluid in humans following intravenous infusion of alatrofloxacin.
- Initial safety, tolerability pharmacodynamics, and pharmacokinetics of CI-1007 in patients with schizophrenia.
- Orthostasis in Alzheimer disease: a retrospective analysis.
- A double-blind, placebo-controlled study of a CCK-B receptor antagonist, CI-988, in patients with generalized anxiety disorder.
- Defining the maximum tolerated dose: investigator, academic, industry and regulatory perspectives.
- Relationship between duration of illness and plasma concentrations of antipsychotics in psychotic patients.
- Evaluation of cycloserine in the treatment of Alzheimer's disease.
- Ongoing trials in Alzheimer''s disease.
- Adverse events in placebo-treated patients with generalized anxiety disorder.
- The use of the Computerized Neuropsychological Test Battery (CNTB) in an efficacy and safety trial of BMY 21,502 in Alzheimer's disease.
- Clinical safety, tolerance, and plasma levels of the oral anticholinesterase 1,2,3,4-tetrahydro-9-aminoacridin-1-oL-maleate (HP 029) in Alzheimer's disease: preliminar...
- Pramipexole in patients with early Parkinson's disease.
- Single-site findings in a study of the safety and efficacy of a CCKB receptor antagonist, CI-988, in the treatment of generalized anxiety disorder.
- Efficacy and safety of BMY 21,502 in Alzheimer disease.
- A new assessment tool for neuropsychopharmacologic research: the Computerized Neuropsychological Test Battery.
- A pilot clinical trial of the angiotensin-converting enzyme inhibitor ceranapril in Alzheimer disease.
- Pharmacokinetic-pharmacodynamic modeling of rivastigmine, a cholinesterase inhibitor, in patients with Alzheimer's disease.
- Effects of treatment with simvastatin and pravastatin on cognitive function in patients with hypercholesterolaemia.
- Recent developments in the drug treatment of Alzheimer''s disease.
- Review of the next generation of Alzheimer''s disease therapeutics: challenges for drug development.
- Exploratory studies: implications for drug development in Alzheimer''s disease.
- Pharmacokinetics and pharmacodynamics of avitriptan in patients with migraine after oral dosing.
- Pilot study of MK-462 in migraine.
- A "bridging" (safety/tolerance) study of besipirdine hydrochloride in patients with Alzheimer''s disease.
- Efficacy and safety of sibutramine for weight loss in obese patients with hypertension well controlled by beta-adrenergic blocking agents: a placebo-controlled, double...
- Pilot study of a CCKB antagonist in patients with panic disorder: preliminary findings.
- Efficacy and safety of two dosing regimens of buspirone in the treatment of outpatients with persistent anxiety.
- The target population in phase I clinical trials of cholinergic compounds in Alzheimer disease: the role of the "bridging study".
- Efficacy of xanomeline in Alzheimer disease: cognitive improvement measured using the Computerized Neuropsychological Test Battery (CNTB).
- A double-blind, randomized, crossover assessment of blood pressure following administration of avitriptan, sumatriptan, or placebo to patients with mild to moderate hy...
- Ethnicity and antipsychotic response.
- Mild cognitive impairment: emerging therapeutics.
- Gender differences in depression and antidepressant pharmacokinetics and adverse events.
- Acetylcholinesterase inhibition by zifrosilone: pharmacokinetics and pharmacodynamics.
- Detection of benzodiazepines in human hair by radioimmunoassay.
- Anti-hypertensive effects of intravenous compared with oral captopril.
Schools
Saint Louis University School of Medicine
St Johns Mercy Hospital
Bethesda Naval Hospital
University Calif
National Institute Of Health
Doctors Specialties
- Psychiatry
Accepted Insurances
Education
-
University of California Irvine -
Saint Louis University School of Medicine
Helpful Reviews
Similar Doctors
|
|
Dr. Serena Puga, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Eleanor Lavretsky, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Edward A. Moore, MD |
|
|
Dr. Marvin P. Osman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Thaddeus M. Juarez, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ellen F. Leeb, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jeffrey S. Gandin, MD |
|
|
Dr. Howard S. Shapiro, MD |
|
|
Dr. Murray N. Weiler, MD |